Pliant Therapeutics (NASDAQ:PLRX) experienced a significant adjustment in their stock price target as Needham analysts revised their expectations from $38.00 to $10.00. Despite the reduction, Needham ...

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX) tumbled 64% following the company's announcement to halt enrollment and ...